Literature DB >> 20675058

Osteoporosis as a potential contributor to the bone metastases.

Yong-Ping Wu1, Wei-Shan Chen, Sheng-Jie Xu, Ning Zhang.   

Abstract

Bone metastasis is a serious complication of patients with tumor, and most primary tumors can metastasize to bone. And the main threat and the reason for most cancer deaths are not the primary neoplasias, but secondary tumors, the metastases. To minimize the morbidity and economic expenditure associated with bone metastases, it is important to decrease the etiological factors of bone metastasis. Although current evidence suggested that the therapies to the underlying malignancy bone metastasis might result in bone loss leading to osteoporosis, no studies have shown direct evidence the successful seeding of bone metastases of cancer cells is the part played by osteoporosis. In the state of osteoporosis, for the enhancement of the osteolysis, the increased inflammatory factors could make blood vessels leakier, resulting in the easier hematogenous metastasis to bone and bone marrow. Moreover, leptin, which was positive correlation with osteoporosis, has been showed to exert angiogenic effects and could regulate VEGF expression, promoting the proliferation of the cancer blood vessel. In addition, the increased growth factors in osteoporosis could enrich the local microenvironment, promoting the growth of the metastasis mass. Given the above background, we hypothesize that osteoporosis may be a potential contributor to the bone metastases.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675058     DOI: 10.1016/j.mehy.2010.07.010

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

Review 1.  Roles of leptin in bone metabolism and bone diseases.

Authors:  Xu Xu Chen; Tianfu Yang
Journal:  J Bone Miner Metab       Date:  2015-03-18       Impact factor: 2.626

2.  Caveolin-1 is critical in the proliferative effect of leptin on osteoblasts through the activation of Akt.

Authors:  Lin Zou; Guichun Zhang; Lifeng Liu; Chen Chen; Xuecheng Cao; Jinfang Cai
Journal:  Mol Med Rep       Date:  2016-07-01       Impact factor: 2.952

3.  Longitudinal analysis of complete blood count parameters in advanced-stage lung cancer patients.

Authors:  Livia Rojko; Zsolt Megyesfalvi; Eszter Czibula; Lilla Reiniger; Vanda Teglasi; Zsolt Szegedi; Zoltan Szallasi; Balazs Dome; Judit Moldvay
Journal:  Thorac Cancer       Date:  2020-09-17       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.